Literature DB >> 22848306

Oridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cells.

Zhe Ji1, Qingjiu Tang, Jinsong Zhang, Yan Yang, Yanfang Liu, Yingjie Pan.   

Abstract

Oridonin, a diterpenoid isolated from Rabdosia rubescens (Hemsl.) Hara, inhibited the growth of human tumor cell lines SW620 (colon), MCF-7 (breast) and K562 (bone marrow), and induced significant levels of apoptosis in SW620. Morphological changes indicative of cell apoptosis were observed after the cells were exposed to oridonin for 24 h. Growth inhibition was associated with G1 phase arrest, and with time- and dose-dependent increases in caspase-3 activity. We therefore conclude that oridonin inhibits the proliferation of SW620 cells by induction of apoptosis via the activation of caspase-3. Our data suggest that oridonin may have significant potential as an anti-colorectal adenocarcinoma agent.

Entities:  

Year:  2011        PMID: 22848306      PMCID: PMC3406505          DOI: 10.3892/ol.2011.408

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

Review 1.  Structure and zymogen activation of caspases.

Authors:  Mrudula Donepudi; Markus G Grütter
Journal:  Biophys Chem       Date:  2002-12-10       Impact factor: 2.352

2.  Antitumor activity of the Isodon diterpenoids: structural requirements for the activity.

Authors:  E Fujita; Y Nagao; M Node; K Kaneko; S Nakazawa; H Kuroda
Journal:  Experientia       Date:  1976-02-15

3.  Terpenoids. LIII. Antitumor activity of trichorabdals and related compounds.

Authors:  K Fuji; M Node; M Sai; E Fujita; S Takeda; N Unemi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-06       Impact factor: 1.645

4.  Rabdosia rubescens inhibits breast cancer growth and angiogenesis.

Authors:  Maryam R Sartippour; Navindra P Seeram; David Heber; Mary Hardy; Andrew Norris; Qingyi Lu; Liping Zhang; Ming Lu; Jian Yu Rao; Mai N Brooks
Journal:  Int J Oncol       Date:  2005-01       Impact factor: 5.650

5.  Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics.

Authors:  Alexander Huether; Michael Höpfner; Andreas P Sutter; Detlef Schuppan; Hans Scherübl
Journal:  J Hepatol       Date:  2005-10       Impact factor: 25.083

6.  Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells.

Authors:  Venkateswaran Subramaniam; Isabella R Vincent; Serge Jothy
Journal:  Exp Mol Pathol       Date:  2005-10-14       Impact factor: 3.362

7.  Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.

Authors:  Takayuki Ikezoe; Sophie S Chen; Xian-Jun Tong; David Heber; Hirokuni Taguchi; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

Review 8.  Death receptor-induced cell killing.

Authors:  Andrew Thorburn
Journal:  Cell Signal       Date:  2004-02       Impact factor: 4.315

9.  Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.

Authors:  Kylie A Hood; Lyndon M West; Berber Rouwé; Peter T Northcote; Michael V Berridge; St John Wakefield; John H Miller
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.

Authors:  S J Martin; C P Reutelingsperger; A J McGahon; J A Rader; R C van Schie; D M LaFace; D R Green
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  7 in total

1.  Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.

Authors:  Fei-Fei Li; Sha Yi; Lu Wen; Jing He; Li-Jing Yang; Jie Zhao; Ben-Ping Zhang; Guo-Hui Cui; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06       Impact factor: 6.150

2.  Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.

Authors:  Ke-Wang Sun; Ying-Yu Ma; Tian-Pei Guan; Ying-Jie Xia; Chang-Ming Shao; Le-Gao Chen; Ya-Jun Ren; Hai-Bo Yao; Qiong Yang; Xu-Jun He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 3.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

4.  The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells.

Authors:  Kelly Hallman; Katie Aleck; Brigitte Dwyer; Victoria Lloyd; Meghan Quigley; Nada Sitto; Amy E Siebert; Sumi Dinda
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-10

5.  Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.

Authors:  Zhuo Yao; Fuhua Xie; Min Li; Zirui Liang; Wenli Xu; Jianhua Yang; Chang Liu; Hongwangwang Li; Hui Zhou; Liang-Hu Qu
Journal:  Cell Death Dis       Date:  2017-02-23       Impact factor: 8.469

6.  Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Rolf Daniels; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2013-09-05       Impact factor: 5.310

Review 7.  Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.

Authors:  Dahong Li; Tong Han; Jie Liao; Xu Hu; Shengtao Xu; Kangtao Tian; Xiaoke Gu; Keguang Cheng; Zhanlin Li; Huiming Hua; Jinyi Xu
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.